Nos publications

Les équipes du CRCM publient chaque année plus de 130 articles de recherche fondamentale, translationnelle et clinique.

En direct

Le Centre de Recherche en Cancérologie de Marseille fête ses 50 ans ! -

Photo de profil par défault
Sep 2022 Cancer medicine

The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro-metastases.

Houvenaeghel G, de Nonneville A, Chopin N, Classe JM, Mazouni C, Chauvet MP, Reyal F, Tunon de Lara C, Jouve E, Rouzier R, Daraï E, Gimbergues P, Coutant C, Azuar AS, Villet R, Crochet P, Rua S, Bannier M, Cohen M, Boher JM

Photo de profil par défault
Aug 2022 EMBO molecular medicine

TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.

de Nonneville A, Salas S, Bertucci F, Sobinoff AP, Adélaïde J, Guille A, Finetti P, Noble JR, Churikov D, Chaffanet M, Lavit E, Pickett HA, Bouvier C, Birnbaum D, Reddel RR, Géli V

Photo de profil par défault
Aug 2022 Blood

Non-canonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias.

Poplineau M, Platet N, Mazuel A, Hérault L, N'guyen L, Koide S, Nakajima-Takagi Y, Kuribayashi W, Carbuccia N, Haboub L, Vernerey J, Oshima M, Birnbaum D, Iwama A, Duprez E

Photo de profil par défault
Aug 2022 Molecular therapy : the journal of the American Society of Gene Therapy

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.

Le TK, Cherif C, Omabe K, Paris C, Lannes F, Audebert S, Baudelet E, Hamimed M, Barbolosi D, Finetti P, Bastide C, Fazli L, Gleave M, Bertucci F, Taïeb D, Rocchi P

Photo de profil par défault
Aug 2022 Science signaling

CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness.

Nigri J, Leca J, Tubiana SS, Finetti P, Guillaumond F, Martinez S, Lac S, Iovanna JL, Audebert S, Camoin L, Vasseur S, Bertucci F, Tomasini R

Photo de profil par défault
Jul 2022 Frontiers in Oncology

Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial

Sabatier R, Garnier S, Guille A, Carbuccia N, Pakradouni J, Adelaide J, Provansal M, Cappiello M, Rousseau F, Chaffanet M, Birnbaum D, Mamessier E, Gonçalves A, Bertucci F

Photo de profil par défault
Jul 2022 Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Interpretable Machine Learning Models to Predict the Resistance of Breast Cancer Patients to Doxorubicin from Their microRNA Profiles.

Ogunleye AZ, Piyawajanusorn C, Gonçalves A, Ghislat G, Ballester PJ

Photo de profil par défault
Jul 2022 Journal of the National Cancer Institute

RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.

de Nonneville A, Finetti P, Mamessier E, Bertucci F

Photo de profil par défault
Jul 2022 Cancers

CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression.

Boudin L, De Nonneville A, Finetti P, Guittard G, Nunes JA, Birnbaum D, Mamessier E, Bertucci F

Photo de profil par défault
Jul 2022 Communications biology

NUPR1 protects against hyperPARylation-dependent cell death.

Santofimia-Castaño P, Huang C, Liu X, Xia Y, Audebert S, Camoin L, Peng L, Lomberk G, Urrutia R, Soubeyran P, Neira JL, Iovanna J